Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Myles Wolf currently holds 53,600 shares of Akebia Therapeutics, Inc. (AKBA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Myles Wolf has been a net neutral trader of AKBA stock. They have purchased $0 and sold $0 worth of shares.
Myles Wolf's most recent insider trade was on Jun 17, 2026, when they sold 53,600 shares at $0.00 per share.
Myles Wolf serves as Executive at Akebia Therapeutics, Inc. (AKBA). They have executed 7 insider transactions totaling $0 over their tenure at the company.
Myles Wolf holds the position of Executive at Akebia Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Myles Wolf has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Myles Wolf was on Jun 17, 2026, when they purchased $0 worth of AKBA shares. This transaction involved 53,600 shares at N/A per share.
Myles Wolf currently owns 53,600 shares of Akebia Therapeutics, Inc. (AKBA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Myles Wolf's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Myles Wolf has 7 Form 4 filings on record as an insider at Akebia Therapeutics, Inc..
Set alerts for Myles Wolf and 40,000+ other insiders.